Favourites
Have ideas?
Sign in
/
Register
Positive
:
Negative
:
Disease: Hypoglycemia segment
RZLT
Rezolute, Inc. - Common Stock
-2.74%
-2.74%
0
+
Biopharma
,
Medicine
,
Disease: Hypoglycemia
Last highlighted: #RZLT SEC report: Rezolute, Inc. Current report, items 7.01 and 9.01
SEC Filing Form 8-K filed by Rezolute, Inc. -- SEC File Number 211161853
+ My List
We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.